Press "Enter" to skip to content

Stocks to Watch: AstraZeneca India, Reliance Infra, IndiGo, HDFC Bank, NTPC

AstraZeneca India: The company on Sunday said it has received import and market permission from the Indian drug regulator for Selumetinib capsules. The capsules are indicated for treatment of pediatric patients 3 years of age and older with neurofibromatosis type 1 and who have symptomatic, inoperable plexiform neurofibromas. Balkrishna Industries: The company on Saturday said it will raise up to ₹1,000 crore through long-term borrowings. In a regulatory filing, the company said its board at a meeting held on Saturday decided to raise "funds up to ₹1,000 crore through broader means of long-term finance". HDFC Bank: The private sector […]

Be First to Comment

    Leave a Reply

    Your email address will not be published. Required fields are marked *